Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVOLVE Antiviral Initiative: Emetine for Dengue Fever
NCT07016321Phase 3Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Sep 2026
- Primary completion
- Mar 2029
- Modality
- Nucleic Acid-Directed Small Molecules, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of Emetine in dengue fever, sponsored by Johns Hopkins University. Started Sep 2026; status: recruiting.
02
Drugs
Emetine
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT07016321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07016321.